Insider sales are trivial in size and involve non-C-suite executives, no actionable signal. Monitor for any material corporate events (e.g., pipeline readouts, regulatory decisions) that could drive the stock, but this cluster alone does not warrant a trade.
TAK drugs
TAK drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 24 $18.24entry
- T+1 · 3mo ago +0.60%α +0.28% · $18.35
- T+5 · 3mo ago −1.43%α −1.89% · $17.98
- T+20 · 8w ago +3.89%α +2.59% · $18.95
- T+59 · todayOpen
- T+60 · in 9h Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Takeda insiders, the President of R&D and the Chief Human Resources Officer, sold a combined $598K in open-market sales over two days. The total is ~0.001% of the $57.3B market cap, well below the 0.1% materiality threshold, and both sales are likely routine portfolio diversification or tax-related. No bullish or bearish signal from this cluster.
Key Financial Metrics
Key Facts
- President of R&D sold 19,651 shares for $363K on 2026-08-19
- Chief Human Resources Officer sold 12,980 shares for $235K on 2026-08-18
- Total cluster value of $598K represents ~0.001% of Takeda's $57.3B market cap
- Both transactions are open-market sales with no insider purchases in the window
Financial Impact
Total insider sales of $598K, immaterial relative to $57.3B market cap
Risk Factors
- Insider sales could be misinterpreted as bearish by retail traders
- No insider buying to offset the selling signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TAK-1787378795017 |
Track record
18 reports on TAK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 29, 202618d ago 6-K Neutral 4/10 No price data
- Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
- Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Viewing Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
- Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers